Total Funding
85
32
Total FundingPost-IPO Equity raised
Growth Score
-5 pts
Heat Score
0 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
See more interactive data and historical milestones on desktop for the best experience
195592
Adamis Pharmaceuticals is a neuro-biotechnology company developing treatments for neuro-based disorders.
- Dennis J. Carlo: Founder & CEO
David C. Benedicto: Chief Financial Officer
About the Company
Adamis Pharmaceuticals is a clinical-stage neuro-biotechnology company focused on the development and commercialization of potential blockbuster products for the treatment of a variety of neuro-based disorders with significant unmet medical needs. It commercializes products in various therapeutic areas, including allergy, opioid overdose, and
respiratory and inflammatory diseases.
